glp-1 weight loss drug news Chart: 1 in 8 Americans Now Use Drugs for The United States GLP-1 Agonists
Description
10.1056/NEJMoa1509225 49

2,3 In addition to these mechanisms, GLP-1 RAs also delay gastric emptying, thereby contributing to enhanced postprandial glucose regulation and increased satiety, ultimately supporting reduced caloric intake and weight management

Endocrinol Metab (Seoul) 2019;34(3):247262

[PubMed] 26.Scheen AJ, Lefbvre PJ

All three medicationsZepbound, Wegovy, and Ozempicwork by influencing the bodys appetite and metabolism through the GLP-1 (glucagon-like peptide-1) pathway

If weight increases by more than 5% from your lowest point, consider restarting at a low maintenance dose rather than waiting for larger regain